| Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies G Schierhout, S McGregor, A Gessain, L Einsiedel, M Martinello, J Kaldor The Lancet Infectious Diseases 20 (1), 133-143, 2020 | 180 | 2020 |
| Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis B Hajarizadeh, EB Cunningham, H Valerio, M Martinello, M Law, ... Journal of hepatology 72 (4), 643-657, 2020 | 142 | 2020 |
| Evaluation of the Xpert HCV viral load finger-stick point-of-care assay FMJ Lamoury, S Bajis, B Hajarizadeh, AD Marshall, M Martinello, ... The Journal of infectious diseases 217 (12), 1889-1896, 2018 | 116 | 2018 |
| Hepatitis C treatment as prevention: evidence, feasibility, and challenges B Hajarizadeh, J Grebely, M Martinello, GV Matthews, AR Lloyd, GJ Dore The lancet Gastroenterology & hepatology 1 (4), 317-327, 2016 | 112 | 2016 |
| Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia B Hajarizadeh, J Grebely, GV Matthews, M Martinello, GJ Dore Journal of viral hepatitis 25 (6), 640-648, 2018 | 98 | 2018 |
| Management of acute HCV infection in the era of direct-acting antiviral therapy M Martinello, B Hajarizadeh, J Grebely, GJ Dore, GV Matthews Nature reviews Gastroenterology & hepatology 15 (7), 412-424, 2018 | 89 | 2018 |
| HCV reinfection incidence among individuals treated for recent infection M Martinello, J Grebely, K Petoumenos, E Gane, M Hellard, D Shaw, ... Journal of viral hepatitis 24 (5), 359-370, 2017 | 87 | 2017 |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ... Cell reports Medicine 2 (4), 2021 | 74 | 2021 |
| Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia S Bajis, L Maher, C Treloar, B Hajarizadeh, FMJ Lamoury, Y Mowat, ... International Journal of Drug Policy 61, 23-30, 2018 | 74 | 2018 |
| HCV cure and reinfection among people with HIV/HCV coinfection and people who inject drugs M Martinello, B Hajarizadeh, J Grebely, GJ Dore, GV Matthews Current HIV/AIDS Reports 14, 110-121, 2017 | 65 | 2017 |
| Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study H Valerio, M Alavi, D Silk, C Treloar, M Martinello, A Milat, A Dunlop, ... Clinical infectious diseases 73 (1), e69-e78, 2021 | 62 | 2021 |
| Moving towards hepatitis C microelimination among people living with human immunodeficiency virus in Australia: the CEASE study M Martinello, J Yee, SR Bartlett, P Read, D Baker, JJ Post, R Finlayson, ... Clinical Infectious Diseases 71 (6), 1502-1510, 2020 | 61 | 2020 |
| Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: the DARE‐C II study M Martinello, E Gane, M Hellard, J Sasadeusz, D Shaw, K Petoumenos, ... Hepatology 64 (6), 1911-1921, 2016 | 59 | 2016 |
| Global elimination of hepatitis C virus by 2030: why not? GJ Dore, M Martinello, M Alavi, J Grebely Nature medicine 26 (2), 157-160, 2020 | 56 | 2020 |
| Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐and post‐universal access to direct‐acting antiviral treatment in … S Bajis, J Grebely, B Hajarizadeh, T Applegate, AD Marshall, ... Journal of viral hepatitis 27 (3), 281-293, 2020 | 49 | 2020 |
| “We are what we eat!” Invasive intestinal mucormycosis: A case report and review of the literature M Martinello, A Nelson, L Bignold, D Shaw Medical mycology case reports 1 (1), 52-55, 2012 | 49 | 2012 |
| Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability DL Burnett, KJL Jackson, DB Langley, A Aggarwal, AO Stella, ... Immunity 54 (12), 2908-2921. e6, 2021 | 43 | 2021 |
| Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: the … S Bajis, J Grebely, L Cooper, J Smith, G Owen, A Chudleigh, ... Journal of viral hepatitis 26 (8), 969-979, 2019 | 43 | 2019 |
| Prevalence and disease burden of HCV coinfection in HIV cohorts in the Asia Pacific region: a systematic review and meta-analysis. M Martinello, J Amin, GV Matthews, GJ Dore AIDS reviews 18 (2), 2016 | 42 | 2016 |
| Short‐duration pan‐genotypic therapy with Glecaprevir/Pibrentasvir for 6 weeks among people with recent hepatitis C viral infection M Martinello, C Orkin, G Cooke, S Bhagani, E Gane, R Kulasegaram, ... Hepatology 72 (1), 7-18, 2020 | 41 | 2020 |
Jason GrebelyProfessor, The Kirby Institute, UNSW SydneyVerified email at kirby.unsw.edu.au
